Home›Appeal letter library

How to appeal a GLP-1 insurance denial.

To appeal a Wegovy or Zepbound insurance denial: (1) identify the specific denial reason in your denial letter, (2) copy the matching appeal letter template from the 9-template library below, (3) gather supporting documentation (BMI records, comorbidity diagnosis, prior drug trial notes), (4) have your prescriber submit within 180 days of the denial date, and (5) escalate to external review if the internal appeal fails. In ACA marketplace plans, 44 percent of appealed coverage denials were reversed in 2023 (KFF). GLP Chart provides 9 free Wegovy and Zepbound appeal letter templates across 7 US health plans and 3 denial reasons, verified July 13.

Initial PA denials occur on roughly 40-60 percent of first-pass GLP-1 prior authorization submissions. Appeal success rates are far higher, often 60-75 percent for level-1 internal appeals and over 80 percent for level-2 or external review. The single most important variable: did the appeal letter directly rebut the specific denial reason cited in the denial letter.

Find my denial reason ↓First-pass PA letter library →

What a GLP-1 prior authorization appeal letter is

A prior authorization appeal letter is a formal written request asking your insurance plan to reverse a denial for a GLP-1 medication such as Wegovy, Zepbound, Ozempic or a compounded semaglutide alternative. It is different from the original PA request: where the PA request argues you qualify for the drug, the appeal argues that the plan made an error in denying the original request, then proves why.

GLP-1 denials are unusually common for three reasons. First, most commercial plans require prior authorization before they will pay for any GLP-1, because the retail cash price runs $900 to $1,400 a month. Second, the PA criteria are specific: plans typically require documented BMI of 30 or higher (or 27 with a comorbidity), six months of supervised diet and exercise documentation, and in many cases a step-therapy requirement to have tried and failed an older drug first. Any gap in that documentation produces a denial. Third, the denial language is often written in plan jargon that does not map cleanly to what your clinician actually documented.

When to use an appeal letter

File an appeal whenever you receive a denial letter from your plan. The denial letter will cite a specific reason: step therapy not met, BMI not documented, lifestyle change not documented, drug is formulary-excluded for obesity, or medical necessity not established. That reason is the key. An appeal that directly rebuts the cited reason with supporting documentation succeeds far more often than one that simply restates the original PA request. In ACA marketplace plans, 44 percent of appealed coverage denials were reversed in 2023 (KFF).

What makes a winning GLP-1 appeal

Three things separate winning GLP-1 appeals from losing ones.

Citing the plan's own policy language.Most denial letters include a policy number. Pull the plan's published PA criteria for that policy and quote the exact threshold you meet. Plans cannot deny an appeal by applying a threshold stricter than their own published criteria. When the letter shows the patient meets the published threshold, the reviewer has limited discretion to uphold the denial.

Patient-specific documentation, not generic statements.A statement that reads "patient has obesity and requires GLP-1 therapy" is nearly always upheld on appeal. A letter that reads "patient has BMI 34.2 documented in clinic note dated [date], has hypertension treated with lisinopril 10mg, and completed 6 months of supervised low-calorie diet as documented in nutritionist visit notes dated [dates]" directly addresses each PA criterion and leaves less room to deny.

Submitting within the deadline. Commercial plans typically allow 180 days from the denial date for a Level 1 internal appeal. Missing that window waives your right to that appeal level. If your situation is urgent, request an expedited review: plans must decide expedited appeals within 72 hours.

The templates on this page are written around each of these three principles. Each one quotes the plan's own PA criteria, leaves labeled blanks for the patient-specific facts your clinician will fill in, and reminds the submitting clinician to note the filing date and deadline.

Pick your denial reason

Find the denial reason that matches the language in your plan's denial letter. Each reason has a specific rebuttal strategy and an appeal letter template tuned to the plans it is most cited under.

Insufficient documentation of lifestyle intervention
Plan denied because the six-month dietary intervention or weight-management program participation is not documented.
Rebuttal: Lifestyle intervention is the most common denial reason because patients and clinicians under-document it. Self-reported diet attempts, gym membership, prior structured-program participation (Weight Watchers, Noom, hospital-based program) or prior anti-obesity medication trials all count toward this requirement. Attach any documentation that demonstrates six months of clinically supervised or self-directed weight loss effort.
Highmark Blue Cross Blue Shield →CareFirst BlueCross BlueShield →
Drug not on formulary, plan excludes obesity drugs
Plan does not cover GLP-1 for obesity indication at all, either because the plan's employer carve-out excludes anti-obesity drugs or because the formulary class is excluded.
Rebuttal: Formulary exclusion is hard to appeal as obesity-indication. The realistic options are: (1) pivot to a non-obesity indication if the patient qualifies (T2D, OSA via SURMOUNT-OSA, CV indication via SELECT), (2) request a formulary exception with documented medical necessity or (3) explore patient-assistance programs and cash-pay alternatives. For Medicare patients, obesity-indication GLP-1 is excluded by federal statute (the 2003 Medicare Modernization Act), but T2D, OSA and CV indications are not.
UnitedHealthcare →Blue Shield of California →Wellcare (Centene) →Ambetter (Centene marketplace) →
Not medically necessary (boilerplate)
Plan returned a generic medical-necessity denial with no specific clinical objection. This is the easiest denial to appeal because the plan has not articulated a defensible clinical reason.
Rebuttal: Boilerplate medical-necessity denials lose appeals at high rates because the plan must articulate a specific clinical reason on the second-level review. The appeal letter walks through the patient-specific clinical evidence, cites the registration trial for the indication and requests that the plan articulate the specific clinical basis for any continued denial.
Highmark Blue Cross Blue Shield →CareFirst BlueCross BlueShield →Molina Healthcare →

How appeals actually work

Most US health plans have three appeal levels: (1) first-level internal review, where a different clinician at the plan reviews the denial, (2) second-level internal review, usually by a panel including external clinicians, and (3) external review by a state- or federally-regulated independent review organization. Each level has a deadline; missing it is the single most common reason an appeal fails on procedure rather than merits.

For most GLP-1 denials, the first-level internal appeal is the one that matters. Most plans approve at this level if the letter directly rebuts the cited denial reason with patient-specific documentation. If the first level is upheld, second-level and external review are usually statutorily required by state insurance law, and at the external-review level the plan must defend the denial against an independent reviewer who applies the approved prescribing information and the trial evidence.

If the appeal does not land and you decide to pay cash in the meantime, the GLP-1 cost guide compares every legitimate path at maintenance dose, starting at the $149-a-month compounded floor.

GLP-1 insurance appeal FAQ

How do I appeal a GLP-1 insurance denial?
Start with a Level 1 internal appeal. Write a letter that quotes the specific denial reason from your denial letter, then rebuts it using your plan's own policy language and your clinical documentation (BMI, comorbidity records, lifestyle documentation, lab results). Submit by fax within the plan's appeal deadline, typically 180 days from the denial date for commercial plans. If Level 1 fails, a Level 2 appeal goes to a different reviewer. After that, external review by an independent organization is available in most states.
What is the most common reason a GLP-1 prior authorization is denied?
The most common GLP-1 PA denial reasons are: step-therapy requirement not met (plan requires you to try and fail an older drug first), missing or inadequate lifestyle documentation (plan requires 6 months of documented dietary and exercise change), BMI documentation missing or not meeting threshold, and medical-necessity language that does not match the plan's clinical criteria. Knowing which reason was cited is the key to a successful appeal, because the rebuttal must address that specific objection.
How long does a GLP-1 insurance appeal take?
A Level 1 internal appeal typically takes 30 to 60 days for commercial plans. Expedited appeals for urgent situations must be decided within 72 hours. External reviews add another 30 to 45 days. Request an expedited review if a delay would seriously jeopardize your health.
What is a step-therapy denial for a GLP-1?
A step-therapy denial means your plan requires you to try and fail a less expensive drug before approving the GLP-1. For weight management, this usually means trying and failing an older medication such as orlistat or phentermine-topiramate. To rebut a step-therapy denial, document any prior use of the required drug, its failure to produce adequate weight loss, or a clinical contraindication that makes the step drug inappropriate for you.

Educational templates only. Educational templates only. Not legal or medical advice. Appeal letters must be signed by the treating clinician (MD, DO, NP, PA) with prescribing authority. Every plan reads the appeal carefully because the alternative is an external review whose decision is binding on the plan. Address the specific denial reason in the first paragraph. Do not fabricate clinical findings.

John Samaras, editor of GLP Chart
John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this site · LinkedIn · Contact
Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.